{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:24:00Z","timestamp":1778055840169,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.cca.2014.03.015","type":"journal-article","created":{"date-parts":[[2014,3,23]],"date-time":"2014-03-23T00:55:50Z","timestamp":1395536150000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Combination of LC\u2013MS\/MS aldosterone and automated direct renin in screening for primary aldosteronism"],"prefix":"10.1016","volume":"433","author":[{"given":"Auni","family":"Juutilainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Savolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarkko","family":"Romppanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Turpeinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esa","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Kemppainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Pulkki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2014.03.015_bb0005","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2014.03.015_bb0010","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.03.015_bb0015","first-page":"57","article-title":"Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area","volume":"29","author":"Westerdahl","year":"2011","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.cca.2014.03.015_bb0020","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tem.2013.05.003","article-title":"Primary aldosteronism: emerging trends","volume":"24","author":"Galati","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.03.015_bb0025","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview: primary aldosteronism\u2014changing concepts in diagnosis and treatment","volume":"144","author":"Young","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.cca.2014.03.015_bb0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2008.01.005","article-title":"Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis","volume":"19","author":"Giacchetti","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.03.015_bb0035","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.03.015_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1530\/EJE-11-1013","article-title":"Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies","volume":"167","author":"Hannemann","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cca.2014.03.015_bb0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.015_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.015_bb0055","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.jacc.2010.01.032","article-title":"Aldosterone\/renin ratio determines peripheral and central blood pressure values over a broad range","volume":"55","author":"Tomaschitz","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cca.2014.03.015_bb0060","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc07-0525","article-title":"Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients","volume":"30","author":"Colussi","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2014.03.015_bb0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.015_bb0070","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1097\/HJH.0b013e32834ab46a","article-title":"Aldosterone-to-renin ratio and nocturnal blood pressure decline in a general population: the Ohasama study","volume":"29","author":"Satoh","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.cca.2014.03.015_bb0075","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ajh.2012.33","article-title":"Aldosterone-to-renin ratio as a predictor of stroke under conditions of high sodium intake: the Ohasama study","volume":"25","author":"Satoh","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cca.2014.03.015_bb0080","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-1406","article-title":"Familial and phenotypic associations of the aldosterone renin ratio","volume":"94","author":"Alvarez-Madrazo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.03.015_bb0085","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1365-2125.1999.00070.x","article-title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study","volume":"48","author":"Lim","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.cca.2014.03.015_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200103000-00001","article-title":"A review of the medical treatment of primary aldosteronism","volume":"19","author":"Lim","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.cca.2014.03.015_bb0095","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.015_bb0100","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12020-012-9609-z","article-title":"Effect of age on aldosterone\/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups","volume":"42","author":"Yin","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.cca.2014.03.015_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360600931831","article-title":"Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension","volume":"44","author":"Rossi","year":"2007","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.cca.2014.03.015_bb0110","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/1354750X.2011.614015","article-title":"Two-site automated chemiluminescent assay for measurement of immunoreactive renin","volume":"16","author":"Gruson","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.cca.2014.03.015_bb0115","first-page":"113","article-title":"Determination of aldosterone in serum by liquid chromatography\u2013tandem mass spectrometry","volume":"862","author":"Turpeinen","year":"2008","journal-title":"J Chromatogr"},{"key":"10.1016\/j.cca.2014.03.015_bb0120","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/clinchem\/48.11.1919","article-title":"Screening for primary aldosteronism: implications of an increased plasma aldosterone\/renin ratio","volume":"48","author":"Schwartz","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.015_bb0125","first-page":"115","article-title":"Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism","volume":"4","author":"Corbin","year":"2011","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1016\/j.cca.2014.03.015_bb0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1258\/acb.2010.010171","article-title":"The clinical utility of two renin mass methods to detect primary hyperaldosteronism compared with renin activity","volume":"48","author":"Wedatilake","year":"2011","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.cca.2014.03.015_bb0135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/HJH.0b013e3283656b54","article-title":"Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism","volume":"32","author":"Jansen","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.cca.2014.03.015_bb0140","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/HJH.0b013e32833d2192","article-title":"The aldosterone\u2013renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma","volume":"28","author":"Rossi","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.cca.2014.03.015_bb0145","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0030-1247545","article-title":"Reference intervals for aldosterone, renin, and the aldosterone-to-renin ratio in the population-based Study of Health in Pomerania (SHIP-1)","volume":"42","author":"Hannemann","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2014.03.015_bb0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cca.2009.01.013","article-title":"Influence of sampling and storage conditions on plasma renin activity and plasma renin concentration","volume":"402","author":"Locsei","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2014.03.015_bb0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.beem.2006.07.007","article-title":"Screening for primary aldosteronism","volume":"20","author":"Schirpenbach","year":"2006","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.03.015_bb0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00004872-200502000-00030","article-title":"Prorenin cryoactivation as a possible cause of normal renin levels in patients with primary aldosteronism","volume":"23","author":"Sealey","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/j.cca.2014.03.015_bb0165","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","article-title":"Activity assays and immunoassays for plasma renin and prorenin: information provided and precautions necessary for accurate measurement","volume":"55","author":"Campbell","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.015_bb0170","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1258\/acb.2010.009230","article-title":"A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin","volume":"47","author":"Dorrian","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.cca.2014.03.015_bb0175","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/HJH.0b013e32833857ad","article-title":"A comparative study on inter and intralaboratory reproducibility of renin measurement with a conventional enzymatic method and a new chemiluminescent assay of immunoreactive renin","volume":"28","author":"Morganti","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.cca.2014.03.015_bb0180","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2004.033159","article-title":"Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays","volume":"50","author":"Perschel","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2014.03.015_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/HYPERTENSIONAHA.107.101287","article-title":"Interpretation of plasma renin concentration in patients receiving aliskiren therapy","volume":"51","author":"Campbell","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.015_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-0031-1295460","article-title":"Factors affecting the aldosterone\/renin ratio","volume":"44","author":"Stowasser","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2014.03.015_bb0195","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1210\/jc.2010-0225","article-title":"Effect of atenolol on aldosterone\/renin ratio calculated by both plasma renin activity and direct renin concentration in healthy male volunteers","volume":"95","author":"Ahmed","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.03.015_bb0200","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.cca.2014.03.015_bb0205","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0030-1248326","article-title":"Aldosterone to renin ratio \u2014 a reliable screening tool for primary aldosteronism?","volume":"42","author":"Tomaschitz","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.cca.2014.03.015_bb0210","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1210\/jc.2010-2918","article-title":"Effect of contraceptives on aldosterone\/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2014.03.015_bb0215","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1210\/jc.2010-1355","article-title":"Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?","volume":"96","author":"Ahmed","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114001235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898114001235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:44:24Z","timestamp":1648673064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898114001235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":43,"alternative-id":["S0009898114001235"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2014.03.015","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of LC\u2013MS\/MS aldosterone and automated direct renin in screening for primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2014.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}